Atriva Therapeutics
Founded Year
2015Stage
Loan | AliveTotal Raised
$42.17MLast Raised
$28.38M | 2 yrs agoAbout Atriva Therapeutics
Atriva Therapeutics develops antiviral therapies. Atriva's product platform draws from selected repurposed MEK kinase inhibitors and focuses on acute viral infections like influenza, RSV or MERS.
Atriva Therapeutics Headquarter Location
Christophstrasse 32
Tuebingen, 72072,
Germany
+49 7071 859 7673
Expert Collections containing Atriva Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Atriva Therapeutics is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
15,535 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Atriva Therapeutics Patents
Atriva Therapeutics has filed 6 patents.
The 3 most popular patent topics include:
- Epidemiology
- Inflammations
- Influenza
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
9/16/2019 | 10/5/2021 | Influenza, Epidemiology, Animal virology, Virology, Pseudomonadales | Grant |
Application Date | 9/16/2019 |
|---|---|
Grant Date | 10/5/2021 |
Title | |
Related Topics | Influenza, Epidemiology, Animal virology, Virology, Pseudomonadales |
Status | Grant |
Latest Atriva Therapeutics News
Mar 28, 2022
Atriva Therapeutics gibt Wirksamkeit seiner Leitsubstanz Zapnometinib gegen Omikron bekannt
Atriva Therapeutics Web Traffic
Atriva Therapeutics Rank
When was Atriva Therapeutics founded?
Atriva Therapeutics was founded in 2015.
Where is Atriva Therapeutics's headquarters?
Atriva Therapeutics's headquarters is located at Christophstrasse 32, Tuebingen.
What is Atriva Therapeutics's latest funding round?
Atriva Therapeutics's latest funding round is Loan.
How much did Atriva Therapeutics raise?
Atriva Therapeutics raised a total of $42.17M.
Who are the investors of Atriva Therapeutics?
Investors of Atriva Therapeutics include European Investment Bank, High-Tech Grunderfonds, Meneldor and Stichting Participatie Atriva.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.